Spectrum Pharmaceuticals/ US84763A1088 /
| 2023-07-31 9:59:52 PM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 1.03USD | - | 122,550 Turnover: 124,444.33 |
-Bid Size: - | -Ask Size: - | 211.42 mill.USD | - | - |
Assets
| 2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | .4490 | .5890 | .3850 | 11.6070 | 3.5770 | ||||||
| Intangible Assets | 164.2340 | 137.1590 | 111.5940 | - | - | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | 212.1180 | 209.6930 | 140.1980 | 19.4130 | 10.1510 | ||||||
| Inventories | 8.7150 | 5.7150 | 3.5500 | - | - | ||||||
| Accounts Receivable | 39.7820 | 32.2600 | 29.8730 | .4410 | .0670 | ||||||
| Cash and Cash Equivalents | 158.2220 | 227.3230 | 157.4800 | 64.4180 | 46.0090 | ||||||
| Current Assets | 216.6500 | 277.7460 | 250.6880 | 244.0200 | 186.6470 | ||||||
| Total Assets | 428.7680 | 487.4390 | 390.8860 | 263.4330 | 196.7980 | ||||||
Liabilities
| 2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 30.4880 | 33.6480 | 44.9190 | 54.2840 | 34.3850 | ||||||
| Long-term debt | 97.0430 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Liabilities to Banks | 0.0000 | 0.0000 | 0.0000 | 0.0000 | - | ||||||
| Provisions | 6.7000 | 1.4000 | 1.5000 | - | - | ||||||
| Liabilities | 192.7420 | 136.1000 | 107.6240 | 73.0400 | 62.5550 | ||||||
| Share Capital | .0800 | .1000 | .1100 | .1130 | .1460 | ||||||
| Total Equity | 236.0260 | 351.3390 | 283.2620 | 190.3930 | 134.2430 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 428.7680 | 487.4390 | 390.8860 | 263.4330 | 196.7980 | ||||||
Income Statement
| 2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 146.4440 | 128.3670 | 109.3330 | - | - | ||||||
| Depreciation (total) | 26.4920 | 27.9720 | 28.4090 | 1.6200 | .2610 | ||||||
| Operating Result | -61.6280 | -96.6600 | -131.1770 | -140.6980 | -169.7340 | ||||||
| Interest Income | -9.4350 | -6.7980 | -.3400 | 4.9960 | 1.3420 | ||||||
| Income Before Taxes | -70.8250 | -108.0260 | -120.0100 | -144.5940 | -171.3320 | ||||||
| Income Taxes | 2.3130 | 16.7780 | -.0010 | 9.2080 | .0600 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | -68.5120 | -91.2480 | -120.0110 | -112.6890 | -160.8680 | ||||||
Per Share
Cash Flow
| 2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -40.4590 | -38.8550 | -62.4030 | -134.6310 | -121.6290 | ||||||
| Cash Flow from Investing Activities | -.6790 | -1.0810 | 1.3730 | 31.9920 | 18.0720 | ||||||
| Cash Flow from Financing | 59.6440 | 108.7210 | -8.4570 | 9.6270 | 85.2300 | ||||||
| Decrease / Increase in Cash | 18.4810 | 69.1010 | -69.8430 | -93.0620 | -18.4090 | ||||||
| Employees | 227 | 215 | 235 | 146 | - | ||||||
